Banner
HomeFocus → Bayer dismisses Essure concerns as safety, legal claims mount

Bayer dismisses Essure concerns as safety, legal claims mount Print E-mail
Written by FHI's Week in Review   
Monday, 30 July 2018 00:00
 
Conor Hale reports for Fierce Healthcare on July 27, 2018:
Bayer pushed back on the clinical safety of its Essure contraceptive implant-a week after the company said it would pull the device from the market at the end of the year due to poor sales-as public and legal pressure continue to mount regarding reports of excessive fatigue, pain and bleeding.The company characterized safety concerns as "based on anecdotal reports, rather than science," telling women and healthcare providers that no "reliable scientific evidence" exists to suggest new problems with the permanent birth control implant, and sought to minimize the FDA's adverse event system.
Read more in the current issue of Week in Review>> https://conta.cc/2K7OBt9
 
Last Updated on Monday, 30 July 2018 17:14
 


Banner
Website design, development, and hosting provided by
Netphiles